SIGNATUREFD, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2021$1,000195
+282.4%
0.00%
Q3 2021$0
-100.0%
51
-80.6%
0.00%
Q2 2021$2,0000.0%263
+22.9%
0.00%
Q1 2021$2,000
+100.0%
2140.0%0.00%
Q4 2020$1,000
-75.0%
214
-65.4%
0.00%
Q3 2020$4,000
-20.0%
619
-17.5%
0.00%
Q2 2020$5,000750
+74900.0%
0.00%
Q2 2019$01
-50.0%
0.00%
Q1 2019$020.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders